The genetic abnormalities in APOB and MTP are well-established to be associated with the development of familial hypobetalipoproteinemia (FHBL) and abetalipoproteinemia (ABL), respectively (57), both of which are characterized by impaired ApoB secretion. This evidence concerns the gene APOB and familial hypobetalipoproteinemia 1.